<DOC>
	<DOCNO>NCT00215501</DOCNO>
	<brief_summary>The purpose study test safety irinotecan cisplatin combination either capecitabine continuous infusion 5-fluorouracil see effect ( good bad ) patient unresectable , advance solid tumor .</brief_summary>
	<brief_title>Capecitabine 5-Fluorouracil Combination With Irinotecan Cisplatin Patients With Solid Tumor Malignancies</brief_title>
	<detailed_description>- This Phase I dose escalation study . The dose drug patient receives assign base upon enter study . Since look high dose capecitabine 5-fluorouracil give safely combination cisplatin irinotecan , everyone participates study receive amount drug . - There four part study : 1 ) Choice treatment , 2 ) Evaluation , 3 ) Chemotherapy 4 ) Follow-up . - The patient patient 's doctor decide form chemotherapy best patient , either pill form continuous infusion . Chemotherapy pill ( capecitabine ) give twice per day 14 day row every 3 week . Continuous infusion ( 5-fluorouracil ) give pump 24 hour day 14 day every 3 week . - Prior initiation therapy extent patient cancer evaluate . This include CT scan , chest x-ray , EKG bloodwork . - Patient 's receive chemotherapy 2 week follow one week break . This constitute one cycle . The medication cisplatin irinotecan give intravenously 1st 8th day cycle . Following rest period next cycle chemotherapy begin . - Following 2 cycle chemotherapy , patient cancer re-evaluated . A CT scan bloodwork obtain compare previous study . Treatment resume cancer size small patient tolerate chemotherapy well . The cancer re-evaluated every 2 cycle chemotherapy .</detailed_description>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Camptothecin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Histologically confirm solid tumor malignancy 18 year age old Two prior chemotherapy regimens metastatic disease . Prior chemotherapy must complete least 3 week prior initiation protocol . ECOG performance status 0,1 2 Neutrophils great equal 1,500/ul Platelets great equal 100,000/ul Serum bilirubin less equal 1.5 mg/dl Creatinine clearance great 50 ml/min AST SGOT less equl 3x ULN Prior radiotherapy allowable , provide least 4 week elapse patient recover therapy related side effect . Life expectancy le 3 month Clinically significant cardiac disease myocardial infarction within past 6 month Suspicion documentation CNS metastases carcinomatous meningitis Psychiatric disability judge investigator clinically significant , preclude informed consent Known exist coagulopathy and/or require therapeutic anticoagulant Uncontrolled diarrhea Peripheral neuropathy Major surgery within 3 week state study treatment without complete recovery Serious , uncontrolled , concurrent infection Lack physical integrity upper gastrointestinal tract malabsorption syndrome Prior severe reaction fluoropyrimidine , irinotecan cisplatin Known interstitial pulmonary fibrosis Known Gilbert 's disease Uncontrolled diabetes mellitus Organ allograft ( ) immunosuppressive therapy Pregnant lactate woman Patients take valproic acid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>advanced solid tumor malignancy</keyword>
	<keyword>capecitabine</keyword>
	<keyword>continuous infusion</keyword>
	<keyword>5-FU</keyword>
	<keyword>irinotecan</keyword>
	<keyword>5-fluorouracil</keyword>
	<keyword>cisplatin</keyword>
</DOC>